{"id":"rh-gcsf","_chembl":{"chemblId":"CHEMBL2326807","moleculeType":"Unknown","molecularWeight":"1183.94"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=rh-GCSF","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T06:58:38.304842+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T06:58:43.128558+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=rh-GCSF","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T06:58:43.737405+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2326807/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:58:44.558206+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T00:04:57.012Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:58:46.138009+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT02527746","phase":"PHASE1","title":"Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy","status":"COMPLETED","sponsor":"EVIVE Biotechnology","startDate":"2012-12","conditions":"Neutropenia, Breast Cancer","enrollment":18},{"nctId":"NCT02521441","phase":"PHASE2","title":"A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.","status":"COMPLETED","sponsor":"EVIVE Biotechnology","startDate":"2014-07-03","conditions":"Neutropenia","enrollment":138},{"nctId":"NCT01479114","phase":"PHASE4","title":"Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on CD11b in Septic Neonates","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2009-04","conditions":"Neonatal Sepsis","enrollment":90},{"nctId":"NCT01441427","phase":"PHASE1, PHASE2","title":"Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2010-01","conditions":"Feeding Intolerance, Necrotizing Enterocolitis","enrollment":93}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2326807"},"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Granulocyte colony stimulating factor,neubogen,filgstrim"],"phase":"marketed","status":"active","brandName":"rh-GCSF","genericName":"rh-GCSF","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:58:46.138009+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}